Experiences with allopurinal in canine endotoxin shock

Area of Science:

• Pharmacology
• Veterinary Medicine
• Critical Care Medicine

Background:

• Endotoxin shock in dogs causes circulatory collapse.
• Allopurinol is a xanthine-oxidase inhibitor with potential cell-stabilizing properties.

Purpose of the Study:

• To evaluate allopurinol as a therapeutic agent for canine endotoxin shock.
• To assess the effects of allopurinol on hemodynamics and survival in endotoxin shock.

Main Methods:

• Canine endotoxin shock model induced by intravenous endotoxin.
• Treatment with allopurinol (25, 50, or 100 mg/kg) and dextran.
• Monitoring of peripheral vascular resistance, cardiac output, blood glucose, and lactate levels.

Main Results:

• Allopurinol significantly reduced peripheral vascular resistance and increased cardiac output.
• Increased blood glucose and arterial lactate concentrations were observed with allopurinol.
• Allopurinol did not enhance survival rates in canine endotoxin shock.
• No significant changes in vascular tone or lactate in normal dogs, but transient hyperglycemia and decreased cardiac index.

Conclusions:

• While allopurinol demonstrated beneficial hemodynamic and metabolic effects in canine endotoxin shock, it did not improve survival.
• Further research may be needed to explore alternative therapeutic strategies for endotoxin shock.